| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of ryanodine-sensitive calcium-release channel activity | 1.20e-06 | 26 | 64 | 4 | GO:0060314 | |
| GeneOntologyBiologicalProcess | calcium ion transport into cytosol | 8.63e-06 | 42 | 64 | 4 | GO:0060402 | |
| GeneOntologyBiologicalProcess | positive regulation of protein O-linked glycosylation | 2.84e-05 | 3 | 64 | 2 | GO:1904100 | |
| GeneOntologyBiologicalProcess | regulation of protein O-linked glycosylation | 2.84e-05 | 3 | 64 | 2 | GO:1904098 | |
| GeneOntologyBiologicalProcess | neuromuscular process controlling balance | 8.24e-05 | 74 | 64 | 4 | GO:0050885 | |
| GeneOntologyBiologicalProcess | release of sequestered calcium ion into cytosol | 9.04e-05 | 146 | 64 | 5 | GO:0051209 | |
| GeneOntologyBiologicalProcess | negative regulation of sequestering of calcium ion | 9.34e-05 | 147 | 64 | 5 | GO:0051283 | |
| GeneOntologyBiologicalProcess | regulation of sequestering of calcium ion | 9.95e-05 | 149 | 64 | 5 | GO:0051282 | |
| GeneOntologyBiologicalProcess | sequestering of calcium ion | 1.13e-04 | 153 | 64 | 5 | GO:0051208 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transmembrane transporter activity | 1.92e-04 | 92 | 64 | 4 | GO:1901019 | |
| GeneOntologyBiologicalProcess | regulation of release of sequestered calcium ion into cytosol | 2.45e-04 | 98 | 64 | 4 | GO:0051279 | |
| GeneOntologyBiologicalProcess | negative regulation of PERK-mediated unfolded protein response | 2.62e-04 | 8 | 64 | 2 | GO:1903898 | |
| GeneOntologyBiologicalProcess | protein geranylgeranylation | 2.62e-04 | 8 | 64 | 2 | GO:0018344 | |
| GeneOntologyBiologicalProcess | regulation of mRNA export from nucleus | 5.12e-04 | 11 | 64 | 2 | GO:0010793 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 5.67e-04 | 217 | 64 | 5 | GO:0097553 | |
| GeneOntologyCellularComponent | junctional membrane complex | 3.10e-11 | 9 | 65 | 5 | GO:0030314 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 6.19e-11 | 10 | 65 | 5 | GO:0014701 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum membrane | 2.76e-07 | 45 | 65 | 5 | GO:0033017 | |
| GeneOntologyCellularComponent | sarcoplasmic reticulum | 3.17e-07 | 88 | 65 | 6 | GO:0016529 | |
| GeneOntologyCellularComponent | sarcoplasm | 1.46e-06 | 114 | 65 | 6 | GO:0016528 | |
| GeneOntologyCellularComponent | Rab-protein geranylgeranyltransferase complex | 5.69e-05 | 4 | 65 | 2 | GO:0005968 | |
| GeneOntologyCellularComponent | polyprenyl diphosphate synthase complex | 6.16e-04 | 12 | 65 | 2 | GO:0032476 | |
| HumanPheno | Calf muscle hypertrophy | 7.55e-05 | 50 | 24 | 4 | HP:0008981 | |
| HumanPheno | Lumbar hyperlordosis | 7.94e-05 | 99 | 24 | 5 | HP:0002938 | |
| HumanPheno | Muscle hypertrophy of the lower extremities | 9.52e-05 | 53 | 24 | 4 | HP:0008968 | |
| HumanPheno | Cerebral cortical atrophy | 1.17e-04 | 346 | 24 | 8 | HP:0002120 | |
| HumanPheno | Proximal amyotrophy | 1.36e-04 | 58 | 24 | 4 | HP:0007126 | |
| HumanPheno | Abnormality of facial musculature | 1.58e-04 | 361 | 24 | 8 | HP:0000301 | |
| HumanPheno | Abnormal facial expression | 1.65e-04 | 185 | 24 | 6 | HP:0005346 | |
| HumanPheno | Meningoencephalocele | 2.11e-04 | 5 | 24 | 2 | HP:0006888 | |
| HumanPheno | Abnormality of the tongue muscle | 2.11e-04 | 5 | 24 | 2 | HP:0040173 | |
| HumanPheno | Abnormal motor neuron morphology | 2.71e-04 | 501 | 24 | 9 | HP:0002450 | |
| HumanPheno | EMG abnormality | 2.87e-04 | 293 | 24 | 7 | HP:0003457 | |
| HumanPheno | Abnormal neuron morphology | 2.97e-04 | 507 | 24 | 9 | HP:0012757 | |
| HumanPheno | Abnormal calf musculature morphology | 2.98e-04 | 71 | 24 | 4 | HP:0001430 | |
| HumanPheno | Fusion of the cerebellar hemispheres | 3.15e-04 | 6 | 24 | 2 | HP:0006899 | |
| HumanPheno | Kinked brainstem | 3.15e-04 | 6 | 24 | 2 | HP:0012793 | |
| HumanPheno | Areflexia | 4.39e-04 | 314 | 24 | 7 | HP:0001284 | |
| HumanPheno | Diffuse white matter abnormalities | 5.45e-04 | 35 | 24 | 3 | HP:0007204 | |
| HumanPheno | Decreased facial expression | 5.77e-04 | 151 | 24 | 5 | HP:0004673 | |
| MousePheno | abnormal sarcoplasmic reticulum morphology | 8.16e-05 | 23 | 52 | 3 | MP:0004088 | |
| MousePheno | increased susceptibility to xenobiotic induced morbidity/mortality | 1.31e-04 | 133 | 52 | 5 | MP:0009766 | |
| MousePheno | abnormal skeletal muscle fiber triad morphology | 1.35e-04 | 5 | 52 | 2 | MP:0009411 | |
| Domain | MORN | 4.12e-12 | 14 | 65 | 6 | SM00698 | |
| Domain | MORN | 6.85e-12 | 15 | 65 | 6 | IPR003409 | |
| Domain | MORN | 6.85e-12 | 15 | 65 | 6 | PF02493 | |
| Domain | Junctophilin | 1.34e-10 | 4 | 65 | 4 | IPR017191 | |
| Domain | RCC1 | 6.21e-07 | 20 | 65 | 4 | PF00415 | |
| Domain | RCC1_1 | 7.65e-07 | 21 | 65 | 4 | PS00625 | |
| Domain | RCC1_2 | 7.65e-07 | 21 | 65 | 4 | PS00626 | |
| Domain | RCC1_3 | 7.65e-07 | 21 | 65 | 4 | PS50012 | |
| Domain | Reg_chr_condens | 9.32e-07 | 22 | 65 | 4 | IPR000408 | |
| Domain | - | 9.32e-07 | 22 | 65 | 4 | 2.130.10.30 | |
| Domain | RCC1/BLIP-II | 1.13e-06 | 23 | 65 | 4 | IPR009091 | |
| Domain | Fibrinogen_C | 2.21e-06 | 27 | 65 | 4 | PF00147 | |
| Domain | FBG | 2.97e-06 | 29 | 65 | 4 | SM00186 | |
| Domain | - | 3.42e-06 | 30 | 65 | 4 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 3.42e-06 | 30 | 65 | 4 | IPR014716 | |
| Domain | FIBRINOGEN_C_1 | 4.46e-06 | 32 | 65 | 4 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 4.46e-06 | 32 | 65 | 4 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 4.46e-06 | 32 | 65 | 4 | PS51406 | |
| Domain | MIR | 4.74e-06 | 10 | 65 | 3 | PS50919 | |
| Domain | MIR | 4.74e-06 | 10 | 65 | 3 | PF02815 | |
| Domain | MIR | 4.74e-06 | 10 | 65 | 3 | SM00472 | |
| Domain | MIR_motif | 4.74e-06 | 10 | 65 | 3 | IPR016093 | |
| Domain | PMT_4TMC | 1.19e-05 | 2 | 65 | 2 | PF16192 | |
| Domain | Rab_escort | 1.19e-05 | 2 | 65 | 2 | IPR001738 | |
| Domain | PMT_4TMC | 1.19e-05 | 2 | 65 | 2 | IPR032421 | |
| Domain | PMT | 1.19e-05 | 2 | 65 | 2 | PF02366 | |
| Domain | Glyco_trans_39/83 | 1.19e-05 | 2 | 65 | 2 | IPR003342 | |
| Domain | Fibrinogen_CS | 3.75e-05 | 19 | 65 | 3 | IPR020837 | |
| Domain | GDI | 7.12e-05 | 4 | 65 | 2 | PF00996 | |
| Domain | GDP_dissociation_inhibitor | 7.12e-05 | 4 | 65 | 2 | IPR018203 | |
| Domain | GlyclTrfase_39-like | 7.12e-05 | 4 | 65 | 2 | IPR027005 | |
| Domain | Fibrinogen_a/b/g_C_2 | 7.73e-05 | 24 | 65 | 3 | IPR014715 | |
| Domain | - | 7.73e-05 | 24 | 65 | 3 | 4.10.530.10 | |
| Domain | CarboxyPept_regulatory_dom | 9.08e-04 | 13 | 65 | 2 | IPR014766 | |
| Domain | - | 9.08e-04 | 13 | 65 | 2 | 2.60.40.1120 | |
| Domain | - | 9.78e-04 | 56 | 65 | 3 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 1.03e-03 | 57 | 65 | 3 | IPR023753 | |
| Domain | CarboxyPept-like_regulatory | 1.57e-03 | 17 | 65 | 2 | IPR008969 | |
| Domain | Zn_pept | 1.76e-03 | 18 | 65 | 2 | SM00631 | |
| Domain | CARBOXYPEPT_ZN_2 | 1.96e-03 | 19 | 65 | 2 | PS00133 | |
| Domain | - | 2.10e-03 | 73 | 65 | 3 | 2.60.120.260 | |
| Domain | CARBOXYPEPT_ZN_1 | 2.18e-03 | 20 | 65 | 2 | PS00132 | |
| Domain | FA58C | 2.40e-03 | 21 | 65 | 2 | SM00231 | |
| Domain | FA58C_3 | 2.40e-03 | 21 | 65 | 2 | PS50022 | |
| Domain | FA58C_1 | 2.40e-03 | 21 | 65 | 2 | PS01285 | |
| Domain | FA58C_2 | 2.40e-03 | 21 | 65 | 2 | PS01286 | |
| Domain | Peptidase_M14 | 2.88e-03 | 23 | 65 | 2 | PF00246 | |
| Domain | Peptidase_M14 | 2.88e-03 | 23 | 65 | 2 | IPR000834 | |
| Domain | F5_F8_type_C | 3.13e-03 | 24 | 65 | 2 | PF00754 | |
| Domain | FA58C | 3.13e-03 | 24 | 65 | 2 | IPR000421 | |
| Domain | GroES-like | 3.13e-03 | 24 | 65 | 2 | IPR011032 | |
| Domain | Galactose-bd-like | 4.30e-03 | 94 | 65 | 3 | IPR008979 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_POMT_TO_POMK | 7.81e-05 | 5 | 40 | 2 | M47610 | |
| Pubmed | 1.53e-11 | 12 | 65 | 5 | 19095005 | ||
| Pubmed | 6.23e-09 | 3 | 65 | 3 | 10891348 | ||
| Pubmed | Junctophilins: a novel family of junctional membrane complex proteins. | 6.23e-09 | 3 | 65 | 3 | 10949023 | |
| Pubmed | Junctophilins 1, 2, and 3 all support voltage-induced Ca2+ release despite considerable divergence. | 6.23e-09 | 3 | 65 | 3 | 35089322 | |
| Pubmed | 6.23e-09 | 3 | 65 | 3 | 14559359 | ||
| Pubmed | Junctophilin-mediated channel crosstalk essential for cerebellar synaptic plasticity. | 2.49e-08 | 4 | 65 | 3 | 17347645 | |
| Pubmed | 2.17e-07 | 7 | 65 | 3 | 22350948 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 11161796 | ||
| Pubmed | Role of N-glycans in maintaining the activity of protein O-mannosyltransferases POMT1 and POMT2. | 3.44e-06 | 2 | 65 | 2 | 19880378 | |
| Pubmed | Expression of CLLD7 and CHC1L Proteins in Oral Epithelial Dysplasia in a Group of Thai Patients. | 3.44e-06 | 2 | 65 | 2 | 38679985 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 21518849 | ||
| Pubmed | Physical and functional association of human protein O-mannosyltransferases 1 and 2. | 3.44e-06 | 2 | 65 | 2 | 16698797 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 18344558 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 26829602 | ||
| Pubmed | POMT1 and POMT2 mutations in CMD patients: a multicentric Italian study. | 3.44e-06 | 2 | 65 | 2 | 18513969 | |
| Pubmed | Deficiency of triad junction and contraction in mutant skeletal muscle lacking junctophilin type 1. | 3.44e-06 | 2 | 65 | 2 | 11535622 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 15385675 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 16809425 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 9175730 | ||
| Pubmed | Different structural organization of the encephalopsin gene in man and mouse. | 3.44e-06 | 2 | 65 | 2 | 12242008 | |
| Pubmed | POMT1 and POMT2 gene mutations result in 2 cases of alpha-dystroglycanopathy. | 3.44e-06 | 2 | 65 | 2 | 34565739 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 19940065 | ||
| Pubmed | Deficiency of triad formation in developing skeletal muscle cells lacking junctophilin type 1. | 3.44e-06 | 2 | 65 | 2 | 12135771 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 10473614 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 16887026 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 28512129 | ||
| Pubmed | Different roles of the two components of human protein O-mannosyltransferase, POMT1 and POMT2. | 3.44e-06 | 2 | 65 | 2 | 21782786 | |
| Pubmed | Cloning and characterization of the human choroideremia gene. | 3.44e-06 | 2 | 65 | 2 | 7981670 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 14699049 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 22020936 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 27802169 | ||
| Pubmed | Role of alpha5beta1 integrin and MIA (melanoma inhibitory activity) in the pathogenesis of vitiligo. | 1.03e-05 | 3 | 65 | 2 | 23664187 | |
| Pubmed | Abnormal features in mutant cerebellar Purkinje cells lacking junctophilins. | 1.03e-05 | 3 | 65 | 2 | 17904530 | |
| Pubmed | Ca2+-dependent proteolysis of junctophilin-1 and junctophilin-2 in skeletal and cardiac muscle. | 1.03e-05 | 3 | 65 | 2 | 23148318 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 29632175 | ||
| Pubmed | POMGnT1, POMT1, and POMT2 mutations in congenital muscular dystrophies. | 1.03e-05 | 3 | 65 | 2 | 20816175 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 25735609 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 18490429 | ||
| Pubmed | Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion. | 1.03e-05 | 3 | 65 | 2 | 24297939 | |
| Pubmed | 1.67e-05 | 604 | 65 | 8 | 38803224 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 17456771 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 24448647 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 15383666 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 15186776 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 31461656 | ||
| Pubmed | 3.43e-05 | 5 | 65 | 2 | 17878207 | ||
| Pubmed | 3.91e-05 | 202 | 65 | 5 | 29540532 | ||
| Pubmed | 3.97e-05 | 497 | 65 | 7 | 23414517 | ||
| Pubmed | REP-2, a Rab escort protein encoded by the choroideremia-like gene. | 5.13e-05 | 6 | 65 | 2 | 8294464 | |
| Pubmed | Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. | 5.13e-05 | 6 | 65 | 2 | 19299310 | |
| Pubmed | 6.13e-05 | 222 | 65 | 5 | 35941108 | ||
| Pubmed | A proteome-wide map of 20(S)-hydroxycholesterol interactors in cell membranes. | 9.56e-05 | 8 | 65 | 2 | 34799735 | |
| Pubmed | 9.56e-05 | 8 | 65 | 2 | 12942785 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 1.10e-04 | 1016 | 65 | 9 | 19056867 | |
| Pubmed | Misexpression of MIA disrupts lung morphogenesis and causes neonatal death. | 1.23e-04 | 9 | 65 | 2 | 18342301 | |
| Pubmed | 1.40e-04 | 1049 | 65 | 9 | 27880917 | ||
| Pubmed | Identification of a novel human angiopoietin-like gene expressed mainly in heart. | 1.53e-04 | 10 | 65 | 2 | 12624729 | |
| Pubmed | 1.53e-04 | 10 | 65 | 2 | 22275070 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | 1.63e-04 | 1070 | 65 | 9 | 23533145 | |
| Pubmed | 1.87e-04 | 11 | 65 | 2 | 12535645 | ||
| Pubmed | [Genetic predisposition to development of toxic liver cirrhosis caused by alcohol]. | 1.87e-04 | 11 | 65 | 2 | 11436564 | |
| Pubmed | 1.97e-04 | 285 | 65 | 5 | 32838362 | ||
| Pubmed | 2.24e-04 | 12 | 65 | 2 | 3863747 | ||
| Pubmed | AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan. | 2.24e-04 | 12 | 65 | 2 | 24256719 | |
| Pubmed | Junctophilin-2 is necessary for T-tubule maturation during mouse heart development. | 2.24e-04 | 12 | 65 | 2 | 23715556 | |
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 2.65e-04 | 13 | 65 | 2 | 11839810 | |
| Pubmed | 2.96e-04 | 170 | 65 | 4 | 15057823 | ||
| Pubmed | 3.60e-04 | 504 | 65 | 6 | 34432599 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 3.86e-04 | 719 | 65 | 7 | 35337019 | |
| Pubmed | 4.06e-04 | 16 | 65 | 2 | 19256485 | ||
| Pubmed | 4.06e-04 | 16 | 65 | 2 | 32994313 | ||
| Pubmed | Congenital Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 4.59e-04 | 17 | 65 | 2 | 20301468 | |
| Pubmed | 4.78e-04 | 193 | 65 | 4 | 19343046 | ||
| Pubmed | Huntingtin interacting proteins are genetic modifiers of neurodegeneration. | 5.16e-04 | 197 | 65 | 4 | 17500595 | |
| Pubmed | 5.90e-04 | 87 | 65 | 3 | 37495603 | ||
| Pubmed | Histone H3 lysine 36 methyltransferase Hypb/Setd2 is required for embryonic vascular remodeling. | 6.39e-04 | 20 | 65 | 2 | 20133625 | |
| Pubmed | Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis. | 6.39e-04 | 20 | 65 | 2 | 19626040 | |
| Pubmed | 6.75e-04 | 568 | 65 | 6 | 9110174 | ||
| Pubmed | Limb-Girdle Muscular Dystrophy Overview – RETIRED CHAPTER, FOR HISTORICAL REFERENCE ONLY | 7.06e-04 | 21 | 65 | 2 | 20301582 | |
| Pubmed | A "double adaptor" method for improved shotgun library construction. | 7.13e-04 | 574 | 65 | 6 | 8619474 | |
| Pubmed | 9.96e-04 | 235 | 65 | 4 | 32614325 | ||
| Pubmed | Angiopoietin-like 2 is essential to aortic valve development in mice. | 1.09e-03 | 26 | 65 | 2 | 36414704 | |
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 1.37e-03 | 256 | 65 | 4 | 32698014 | |
| Pubmed | Chromosomal assignments of 23 biochemical loci of the rat by using rat x mouse somatic cell hybrids. | 1.45e-03 | 30 | 65 | 2 | 1914521 | |
| Cytoband | 4q31.21 | 6.28e-04 | 26 | 65 | 2 | 4q31.21 | |
| Cytoband | 20q13.12 | 3.31e-03 | 60 | 65 | 2 | 20q13.12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q43 | 3.53e-03 | 62 | 65 | 2 | chr1q43 | |
| Cytoband | 17q21 | 3.65e-03 | 63 | 65 | 2 | 17q21 | |
| Cytoband | 19p13.2 | 4.26e-03 | 229 | 65 | 3 | 19p13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q14 | 5.08e-03 | 244 | 65 | 3 | chr13q14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 5.45e-03 | 797 | 65 | 5 | chr19p13 | |
| GeneFamily | Fibrinogen C domain containing|Angiopoietin like | 6.96e-07 | 8 | 43 | 3 | 905 | |
| GeneFamily | MIA family | 1.66e-05 | 3 | 43 | 2 | 1300 | |
| GeneFamily | Fibrinogen C domain containing | 2.78e-05 | 25 | 43 | 3 | 554 | |
| GeneFamily | Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis | 1.97e-04 | 9 | 43 | 2 | 430 | |
| GeneFamily | Carboxypeptidases | 1.13e-03 | 21 | 43 | 2 | 1321 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 3.96e-03 | 134 | 43 | 3 | 861 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 8.12e-03 | 57 | 43 | 2 | 1179 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.96e-06 | 196 | 65 | 5 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 198 | 65 | 5 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-05 | 198 | 65 | 5 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.48e-05 | 126 | 65 | 4 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-|COVID-19_Mild / Disease condition and Cell class | 4.05e-05 | 131 | 65 | 4 | ae5eb9c013674b36987bf26d4f752dbb374f547b | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar-Club_cell|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.68e-05 | 149 | 65 | 4 | 82edfecb7981d8c336cf9da7aa7e2b3f7a017a3f | |
| ToppCell | E18.5-samps-Epithelial-Epithelial-non_alveolar|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.68e-05 | 149 | 65 | 4 | 14a01ae540db8a350ea26a350b2e6ce6c07639d9 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.86e-05 | 150 | 65 | 4 | b6f1fc62d08199fed6156c7cd32f66d9926531b5 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-CD8_Naive|Int-URO / Disease, Lineage and Cell Type | 7.22e-05 | 152 | 65 | 4 | 52d6f9cf1f4637c922f582705d625b4cbe3dc0c2 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.99e-05 | 156 | 65 | 4 | 2cd007b423c2395c5ce331902e7f27c805755eb3 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 166 | 65 | 4 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 166 | 65 | 4 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.11e-04 | 170 | 65 | 4 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-04 | 171 | 65 | 4 | 2b7c5a557c4bc5c573211c4d618bdd6766a24916 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.14e-04 | 171 | 65 | 4 | dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.30e-04 | 177 | 65 | 4 | 452ec2df36c6d656a7cdadc55be545ccdb146a29 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.33e-04 | 178 | 65 | 4 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.33e-04 | 178 | 65 | 4 | 8591a40fced747ac16b3e8ebc7a22dfb3ad76da2 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.39e-04 | 180 | 65 | 4 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 183 | 65 | 4 | 2f0dcc65ad4d90ef946919b4462280fdd20c5ea0 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 183 | 65 | 4 | 0f02136359787bd78146617990968baa47a65d86 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.51e-04 | 184 | 65 | 4 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 185 | 65 | 4 | 7b1c5d99bd7a6e148524029758cee244a17f5d09 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.54e-04 | 185 | 65 | 4 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 185 | 65 | 4 | e9033a03d574956cf3ae228740b3166e40a6397f | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 185 | 65 | 4 | 578f12c6b2e33d09598dc8e022a20c8555d1325c | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 187 | 65 | 4 | dba4924d914a7dcd4901142684ba920c2404860b | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 187 | 65 | 4 | 9688141beef4f62613d7a810c5872ccb9afc1a71 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 189 | 65 | 4 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 189 | 65 | 4 | 63449d9f1e78ff2bc8786eb88a0d177fe30c7f4d | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 189 | 65 | 4 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 189 | 65 | 4 | f7e2ee5047792ab9ef6472fa88e2d193cdea6fa0 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 189 | 65 | 4 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 190 | 65 | 4 | bfbdf16d488359d7935a419c4c1823288f39c183 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 190 | 65 | 4 | eb1f8bb4d903b08e50c2dc173b06c0c79d8e316e | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-04 | 193 | 65 | 4 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | 18-Distal-Mesenchymal-Cartilage|Distal / Age, Tissue, Lineage and Cell class | 1.81e-04 | 193 | 65 | 4 | 52f3d1bb8d8ca91ba12439d46392f377928ff8f8 | |
| ToppCell | COVID-19-Myeloid-TRAM1|Myeloid / Condition, Lineage and Cell class | 1.81e-04 | 193 | 65 | 4 | 6e6a7f4e50c8ae70bc187b9ce77140a7049dd288 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.81e-04 | 193 | 65 | 4 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-04 | 194 | 65 | 4 | 93bc72a933ccc6a760e5353f072afb606571c6fc | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 195 | 65 | 4 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-04 | 195 | 65 | 4 | 26a3a5daf389606ef1ebb35533f12e60853b3a12 | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-04 | 196 | 65 | 4 | ce13af36fc2932e8125013041742593ff3d07e86 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-04 | 196 | 65 | 4 | acbb493dbb49a33f20cf11106363f7ed51209706 | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-04 | 196 | 65 | 4 | 96e5c6d155273e82ebafa180df8bb589c3e3e54e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-04 | 197 | 65 | 4 | ba6393671a980a1d439307601d18db70a1b1e1f3 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.00e-04 | 198 | 65 | 4 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-04 | 198 | 65 | 4 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.00e-04 | 198 | 65 | 4 | 8a4b4bb6839b9ec52ff0b9c7b39cec8d9a9525bd | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-CD8+_T_naive|Int-URO / Disease, condition lineage and cell class | 2.00e-04 | 198 | 65 | 4 | 8c7d00d8c27fb47954d8ac53eebc4582e92b970c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 199 | 65 | 4 | 103f657132e830a0e5efeb745afb4b77c208a1fa | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.04e-04 | 199 | 65 | 4 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-04 | 199 | 65 | 4 | fde8e3ba19d19069a4d3b8db55bfe6220cf634d5 | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-Adventitial_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.04e-04 | 199 | 65 | 4 | ab0589c068c24aa989bdca083504fbad0c15221d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-04 | 200 | 65 | 4 | 933b5b400e48a511ba0a056be1d33d3610b5f10d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Cortical_neuron|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-04 | 200 | 65 | 4 | 458fb0f40c1720f1cacedf78c40bd059692bfc62 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-TRAM-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.08e-04 | 200 | 65 | 4 | 7c56935446f10d202eafa1f9ee7cb0aae4c2607e | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.08e-04 | 200 | 65 | 4 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.08e-04 | 200 | 65 | 4 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | d2fcd3bd7c3223875f027eeb48ff621192a5f242 | |
| ToppCell | distal-mesenchymal-Myofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.08e-04 | 200 | 65 | 4 | 61854a459385cd9295be37157a8f81a2c227dff3 | |
| Disease | Congenital muscular dystrophy | 1.92e-06 | 12 | 62 | 3 | cv:C0699743 | |
| Disease | choroideremia (implicated_via_orthology) | 4.34e-06 | 2 | 62 | 2 | DOID:9821 (implicated_via_orthology) | |
| Disease | Cobblestone Lissencephaly | 1.30e-05 | 3 | 62 | 2 | C0431376 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.54e-05 | 71 | 62 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 | 4.33e-05 | 5 | 62 | 2 | cv:C4284790 | |
| Disease | lissencephaly (is_implicated_in) | 4.33e-05 | 5 | 62 | 2 | DOID:0050453 (is_implicated_in) | |
| Disease | Walker-Warburg syndrome (is_implicated_in) | 4.33e-05 | 5 | 62 | 2 | DOID:0050560 (is_implicated_in) | |
| Disease | MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 1 | 4.33e-05 | 5 | 62 | 2 | 236670 | |
| Disease | Qualitative or quantitative defects of alpha-dystroglycan | 6.48e-05 | 6 | 62 | 2 | cv:C2936406 | |
| Disease | Walker-Warburg syndrome (implicated_via_orthology) | 9.06e-05 | 7 | 62 | 2 | DOID:0050560 (implicated_via_orthology) | |
| Disease | Autosomal Dominant Myotubular Myopathy | 3.34e-04 | 13 | 62 | 2 | C3661489 | |
| Disease | Centronuclear myopathy | 3.34e-04 | 13 | 62 | 2 | C0175709 | |
| Disease | X-linked centronuclear myopathy | 3.34e-04 | 13 | 62 | 2 | C0410203 | |
| Disease | Congenital Structural Myopathy | 3.34e-04 | 13 | 62 | 2 | C0752282 | |
| Disease | Myopathy, Centronuclear, 1 | 3.34e-04 | 13 | 62 | 2 | C4551952 | |
| Disease | MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K | 3.89e-04 | 14 | 62 | 2 | C1836373 | |
| Disease | Myopathy, Centronuclear, Autosomal Dominant | 3.89e-04 | 14 | 62 | 2 | C1834558 | |
| Disease | alpha-Dystroglycanopathies | 3.89e-04 | 14 | 62 | 2 | C2936406 | |
| Disease | Muscle eye brain disease | 3.89e-04 | 14 | 62 | 2 | C0457133 | |
| Disease | Tubular Aggregate Myopathy | 3.89e-04 | 14 | 62 | 2 | C0410207 | |
| Disease | Fukuyama Type Congenital Muscular Dystrophy | 3.89e-04 | 14 | 62 | 2 | C0410174 | |
| Disease | Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1 | 3.89e-04 | 14 | 62 | 2 | C4284790 | |
| Disease | Walker-Warburg congenital muscular dystrophy | 4.48e-04 | 15 | 62 | 2 | C0265221 | |
| Disease | Autosomal Recessive Centronuclear Myopathy | 4.48e-04 | 15 | 62 | 2 | C3645536 | |
| Disease | muscular dystrophy (is_implicated_in) | 5.79e-04 | 17 | 62 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Congenital Fiber Type Disproportion | 6.50e-04 | 18 | 62 | 2 | C0546264 | |
| Disease | angiopoietin-related protein 1 measurement | 6.50e-04 | 18 | 62 | 2 | EFO_0801382 | |
| Disease | pre-eclampsia (is_implicated_in) | 1.26e-03 | 25 | 62 | 2 | DOID:10591 (is_implicated_in) | |
| Disease | Muscular Dystrophies, Limb-Girdle | 2.07e-03 | 32 | 62 | 2 | C0686353 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SWDFGTGAGFYVDAT | 96 | P10768 | |
| LAAVSGAEGWGYYGC | 11 | P78357 | |
| AGGYPYSFWIGRNEE | 686 | P78357 | |
| NGDYIEGYFSGEWGS | 1241 | Q96Q42 | |
| DGIFWAEYRGGSYSL | 466 | O95841 | |
| RYQDGVYWAEFRGGS | 461 | Q9UKU9 | |
| GSDVHYWEYGRIGNF | 46 | Q00796 | |
| SWYADRPAGTYSGGN | 1916 | Q8IZY2 | |
| YGTWNSGTNRGYEGY | 31 | Q9ULX6 | |
| GDRATWFGLYYNISG | 221 | Q16853 | |
| GYEKAYEGGSELGGW | 426 | Q8N436 | |
| SYYGGNWASFSFSGL | 41 | P24386 | |
| SYYGGNWASFSFSGL | 41 | P26374 | |
| GGDAPTEDDYWGGYG | 361 | Q86UN3 | |
| TEDDYWGGYGGEDQR | 366 | Q86UN3 | |
| VLDNGEVYGWGYNGN | 196 | Q8NDN9 | |
| VDTGEVYVWGYNGNG | 221 | O95199 | |
| GQVYAWGANSYGQLG | 276 | O95199 | |
| GAGYNNTFPYSWGGF | 306 | O95897 | |
| NGAGEFWAGSVYGDG | 76 | Q9NRC9 | |
| WGYSGRGGYQHVRSE | 1056 | Q01804 | |
| GYQYGKAVFGGWSRG | 1246 | Q8IY17 | |
| GEYSGSWNFGFEVAG | 36 | Q9BR39 | |
| AGLNGYKGYGVGDWL | 36 | Q96QH8 | |
| DYAEVGRVGYVSGWG | 271 | P00738 | |
| GFGFSNAGTYGYWPS | 471 | Q86Y46 | |
| SSGRFAGREWYYGNV | 276 | O43639 | |
| GGYLYIIGGAESWNC | 511 | Q9Y6Y0 | |
| TLAGWGELYGRSGYN | 146 | Q8NCE2 | |
| YRSNGSYVDGWFGGE | 3011 | Q15751 | |
| SYVDGWFGGECGSGN | 3016 | Q15751 | |
| YAGLWKDGFQDGYGT | 106 | Q96JJ6 | |
| ETYGDGGTYQGQWAG | 121 | Q9HDC5 | |
| SYLGSWGFSIVGGYE | 606 | Q8N448 | |
| GPSAGYRWASGAQGY | 21 | P53370 | |
| RLYGGFYTDWVSGGQ | 56 | Q9NZB2 | |
| GGYLGGFDGNFLWNR | 76 | Q9Y6A1 | |
| GEYFAYGLSASGSDW | 136 | P48147 | |
| FSWAAGQGYCQGGFS | 196 | P08648 | |
| MYSGNRSGGHGYWDG | 1 | Q9H1Y3 | |
| GFQEFYIQGGDWGSL | 216 | P07099 | |
| YEVAAAEGAGYNGWT | 296 | Q66K79 | |
| FGTLFGLLSWYGTYG | 221 | Q8N6M3 | |
| DWGEKGYYYLHRGSG | 456 | Q9UBX1 | |
| VSWGIGCGEGYDFYT | 456 | Q9NZP8 | |
| RYQDGVYWAEFRGGA | 441 | Q8NI99 | |
| WYFGNADKERSGPYG | 976 | O75165 | |
| QGVRNYWVAIGFGYG | 386 | Q9UI17 | |
| YAGGTNFWGGTKEDD | 846 | Q16760 | |
| SFYRPWGSGSGFGYS | 71 | Q8IUC3 | |
| IGGIWVTYEYGSYRG | 1541 | Q9Y4K1 | |
| QSEGDYLGGEAYWAG | 356 | Q9Y512 | |
| WGGNGVGDDLYSYGF | 701 | P21817 | |
| RLFWGGSVQGDYYGD | 81 | Q16674 | |
| GYGINGTGDSNDFWR | 441 | Q9UKY4 | |
| GFEDWYSGYFGTASL | 296 | Q7RTX9 | |
| YYETVAGGAGAGPSW | 1116 | O14841 | |
| AASRGNGEYAWYYEG | 96 | Q9NTX7 | |
| GNWTGDYEGGTAPYK | 231 | P49221 | |
| DSSSWSHRYGGGGRY | 616 | Q8N7X1 | |
| GGGEYEVQEGFGWTN | 526 | O43280 | |
| RWYADGAVFSGGGDE | 506 | Q96DN2 | |
| GSAVFGYEGWLAGYQ | 151 | P45880 | |
| EQYGGTRDYWQGNGY | 1291 | Q9BYW2 | |
| GEEGDGASGYDAYWK | 241 | Q9Y3S2 | |
| DYTYWVEYTGDGGGT | 416 | Q9HD43 | |
| GSFTYSSGEEYRGEW | 6 | Q8NDC4 | |
| RFNFDDGGSYCGGWE | 6 | Q8WXH2 | |
| GSIYVWASGDGGSYD | 301 | P16519 |